Hein, Marc D.
Chawla, Anshika
Cattaneo, Maurizio
Kupke, Sascha Y.
Genzel, Yvonne http://orcid.org/0000-0002-2652-5943
Reichl, Udo
Funding for this research was provided by:
Defense Advanced Research Projects Agency (W911NF-17-2-0012)
Max Planck Institute for Dynamics of Complex Technical Systems (MPI Magdeburg)
Article History
Received: 11 June 2021
Revised: 25 August 2021
Accepted: 26 August 2021
First Online: 14 September 2021
Change Date: 16 February 2022
Change Type: Update
Change Details: Open Access funding enabled and organized by Projekt DEAL has been added as funding.
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: MC is the co-founder and a shareholder of Artemis Biosystems, Inc. A patent for the use of DI244 as an antiviral agent for treatment of coronavirus infection is pending. Patent holders are SYK, MH, and UR.